Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations

Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations

Detalles Bibliográficos
Main Authors:	Corrias, A, Jie, X, Romero, L, Bishop, M, Bernabeu, M, Pueyo, E, Rodriguez, B
Formato:	Journal article
Publicado:	2010

Títulos similares

Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations
por: Rodriguez B Corrias A Jie A Romero L Bishop MJ Bernabeu MO Pueyo E
Publicado: (2010)

Impact of Multiple Ionic Changes in Arrhythmic Risk Biomarkers in Human Ventricular Electrophysiology
por: Rodriguez, J, et al.
Publicado: (2012)

Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity
por: Passini, E, et al.
Publicado: (2017)

Cardiotoxicity of antimalarial drugs.
por: White, N
Publicado: (2007)

Multiscale modelling and simulation investigation of variability and abnormalities in repolarization: application to drug cardiotoxicity
por: Rodriguez, B
Publicado: (2010)

Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk
por: Pueyo, E, et al.
Publicado: (2010)

Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk.
por: Pueyo, E, et al.
Publicado: (2010)

Toward a broader view of mechanisms of drug cardiotoxicity
por: Mamoshina, P, et al.
Publicado: (2021)

A new ECG biomarker for drug toxicity: A combined signal processing and computational modeling study
por: Jie, X, et al.
Publicado: (2010)

A new ECG biomarker for drug toxicity: A combined signal processing and computational modeling study
por: Jie, X, et al.
Publicado: (2010)

Human and rabbit inter−species comparison of ionic mechanisms of arrhythmic risk: A simulation study
por: Romero, L, et al.
Publicado: (2010)

Global Sensitivity Analysis of Arrhythmic Risk Biomarkers in Cardiac Single Cell Models
por: Sher, A, et al.
Publicado: (2012)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
por: Mincholé, A, et al.
Publicado: (2015)

In silico methods for the prediction of drug-induced cardiotoxicity
por: Mamoshina, P
Publicado: (2020)

The cardiotoxicity of antimalarials
Publicado: (2017)

Assessing cardiotoxicity in randomised trials of anthracycline chemotherapy
por: Kerr, A
Publicado: (2016)

Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator
por: McMillan, B, et al.
Publicado: (2017)

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
por: Haeusler, I, et al.
Publicado: (2018)

Establishing a scientific visualization framework to assess drug-induced cardiotoxicity using transgenic zebrafish
por: Ismail Osman
Publicado: (2014)

Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity
por: Mamoshina, P, et al.
Publicado: (2020)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
por: Passini, E, et al.
Publicado: (2015)

Multiscale human-based computer modelling and simulation for investigations of arrhythmic risk in acute ischemia
por: Martinez-Navarro, H
Publicado: (2020)

Torsadogenic drug−induced increased short−term variability of JT−area
por: Jie, X, et al.
Publicado: (2010)

Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
por: Mirams, G, et al.
Publicado: (2012)

In silico investigations into human ventricular pro-arrhythmic mechanisms combined with in vivo and in vitro experiments
por: Zhou, X
Publicado: (2016)

Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.
por: Mirams, G, et al.
Publicado: (2012)

Extracorporeal life support for severe drug-induced cardiotoxicity: a promising therapeutic choice.
por: Ashrafian, H, et al.
Publicado: (2009)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischemia and its modulation by sodium current availability
por: Martinez-Navarro, H, et al.
Publicado: (2020)

Computational probabilistic quantification of pro-arrhythmic risk from scar and left-to-right heterogeneity in the human ventricles
por: Wallman, M, et al.
Publicado: (2013)

The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects.
por: Camen, G, et al.
Publicado: (2013)

The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects
por: Camen, G, et al.
Publicado: (2013)

Machine learning techniques for arrhythmic risk stratification: a review of the literature
por: Chung, Cheuk T., et al.
Publicado: (2022)

High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence
por: Martinez-Navarro, H, et al.
Publicado: (2019)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
por: van Vugt, M, et al.
Publicado: (1999)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
por: Lyon, A, et al.
Publicado: (2018)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: Coleman, JA, et al.
Publicado: (2024)

Targeting p21-activated kinase 1 for development of a novel anti-arrhythmic drug class.
por: He, Y, et al.
Publicado: (2023)

The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity
por: Timm, KN, et al.
Publicado: (2020)

Simulating Drug−Induced Effects on the Heart: From Ion Channel to Body Surface Electrocardiogram
por: Zemzemi, N, et al.
Publicado: (2011)

Simulating drug−induced effects on the heart: from ion channel to body surface electrocardiogram
por: Zemzemi, N, et al.
Publicado: (2011)